Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli
This article aims to review the present status of anti-flavivirus subunit vaccines, both those at
the experimental stage and those already available for clinical use. Aspects regarding …
the experimental stage and those already available for clinical use. Aspects regarding …
Can complementary prime-boost immunization strategies be an alternative and promising vaccine approach against dengue virus?
Dengue is one of the most important diseases transmitted by mosquitoes. Dengvaxia®, a
vaccine registered in several countries, cannot be administered to non-immune individuals …
vaccine registered in several countries, cannot be administered to non-immune individuals …
Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques
MK McCracken, CH Kuklis, CB Kannadka, DA Barvir… - npj Vaccines, 2021 - nature.com
Antibody-dependent enhancement (ADE) is suspected to influence dengue virus (DENV)
infection, but the role ADE plays in vaccination strategies incorporating live attenuated virus …
infection, but the role ADE plays in vaccination strategies incorporating live attenuated virus …
Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice
Zika virus infection continues to be a global concern for human health due to the high-risk
association of the disease with neurological disorders and microcephaly in newborn …
association of the disease with neurological disorders and microcephaly in newborn …
B1 protein: a novel cell penetrating protein for in vitro and in vivo delivery of HIV-1 multi-epitope DNA constructs
Objectives Enhancement of the potential ability of biomacromolecules to cross cell
membranes is a critical step for development of effective therapeutic vaccine especially DNA …
membranes is a critical step for development of effective therapeutic vaccine especially DNA …
'Mix and Match'vaccination: Is dengue next?
CD Odio, LC Katzelnick - Vaccine, 2022 - Elsevier
The severity of the COVID-19 pandemic and the development of multiple SARS-CoV-2
vaccines expedited vaccine 'mix and match'trials in humans and demonstrated the benefits …
vaccines expedited vaccine 'mix and match'trials in humans and demonstrated the benefits …
Esquemas de inmunización complementaria basados en la combinación de una formulación tetravalente de proteínas recombinantes y virus vivos atenuados como …
El dengue es una de las enfermedades emergentes más importantes, con solo una vacuna
aprobada y licenciada para su control (Dengvaxia®), su uso limitado por el riesgo de …
aprobada y licenciada para su control (Dengvaxia®), su uso limitado por el riesgo de …
[PDF][PDF] Heterologous prime-boost strategy based on the combination of a tetravalent vaccine of recombinant proteins and live-attenuated virus as a promising vaccine …
Dengue, is one of the most important emerging disease around the world. Currently, only
one vaccine has been approved and licensed against DENV, Dengvaxia®; however, its use …
one vaccine has been approved and licensed against DENV, Dengvaxia®; however, its use …